Peripheral Artery Disease: United States Endovascular Procedure Market by Disease Severity and Vascular Territory Aortoiliac, Femoropopliteal and Infrapopliteal 2015-2040

This report estimates the number of peripheral artery disease (PAD) patients and limbs undergoing endovascular revascularization in the U.S. for the 2015-2040 period. Market estimates are provided in 5-year increments.

THE SAGE GROUP’S 2015-2040 prevalence of PAD, critical limb ischemia (CLI) and intermittent claudication (IC) is the starting point for this model-based, market analysis.

Prevalence is defined as the total number of PAD cases (both new and old) occurring in the population during a specific time period.

The number of endovascular patient and limb procedures are estimated separately for those with CLI or IC. The total market for PAD endovascular procedures is the sum of the two separate estimates.

Endovascular procedures are estimated for CLI and IC patients and limbs by vascular territory in the aortoiliac (AI), femoropopliteal (FP) and infrapopliteal (IP) locations. The total market for AI, FP and IP endovascular procedures is the sum of the two separate estimates.

The percentage of the PAD population currently revascularized and undergoing endovascular revascularization is based on a review of the literature. The percentage of CLI and IC patients revascularized with endovascular and percentage undergoing these procedures by vascular territory, or AI, FP and IP locations, is also based on that found in the literature.

A separate analysis of the endovascular market for popliteal artery (PA) disease is included. Beginning with popliteal disease as a percentage of FP disease found in the literature, the number of endovascular popliteal procedures is estimated separately for those with CLI and IC. The total market for popliteal endovascular procedures is the sum of the two separate estimates

Endovascular popliteal procedures are also estimated for CLI and IC patients and limbs by popliteal segment, or disease treated in the P1, P2 and P3 segments. The total market for P1, P2 and P3 endovascular procedures is the sum of the two separate estimates. The percentage of popliteal disease in each segment is based on that found in the literature.

Price: $6,200

To Purchase:
Call 404-520-6652 or
Contact: yost@thesagegroup.us